[Safety limit of our myocardial protection method, and possibility of glutamate enriched asanguineous secondary cardioplegia].
Shibata
E
E
Andou
F
F
Akagawa
H
H
Yanagi
I
I
Shima
H
H
Yamashita
M
M
Ouryouji
A
A
Isomura
T
T
Hara
H
H
Kosuga
K
K
D000818:Animals; D002314:Cardioplegic Solutions; D004285:Dogs; D004734:Energy Metabolism; D006324:Heart Arrest, Induced / Q000379:methods*; D019344:Lactic Acid / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D012449:Safety; D012970:Sodium Glutamate; D013997:Time Factors; D016277:Ventricular Function, Left
D002314:Cardioplegic Solutions; D019344:Lactic Acid; D012970:Sodium Glutamate